Tamoxifen Action in ER-Negative Breast Cancer

por Manna, Subrata, Holz, Marina K.
Publicado 2016

RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer

por Cuesta, Rafael, Holz, Marina K.
Publicado 2016

The therapeutic potential of resveratrol: a review of clinical trials

por Berman, Adi Y., Motechin, Rachel A., Wiesenfeld, Maia Y., Holz, Marina K.
Publicado 2017

Phosphoproteomics Reveals Resveratrol-Dependent Inhibition of Akt/mTORC1/S6K1 Signaling

por Alayev, Anya, Doubleday, Peter F., Berger, Sara Malka, Ballif, Bryan A., Holz, Marina K.
Publicado 2014

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer

por Bostner, Josefine, Alayev, Anya, Berman, Adi Y., Fornander, Tommy, Nordenskjöld, Bo, Holz, Marina K., Stål, Olle
Publicado 2017

Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation

por Maruani, D. Myriam, Spiegel, Tirtza N., Harris, Emily N., Shachter, Avielle S., Unger, Helen A., Herrero-González, Sandra, Holz, Marina K.
Publicado 2012

ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism

por Berman, Adi Y, Manna, Subrata, Schwartz, Naomi S, Katz, Yardena E, Sun, Yang, Behrmann, Catherine A, Yu, Jane J, Plas, David R, Alayev, Anya, Holz, Marina K
Publicado 2017